Vistakon debuts silicone hydrogel daily wear

Article

The first contact lens that combines the comfort of silicone hydrogel and the convenience and eye health characteristics of a daily wear disposable lens was introduced here at the AOA.

Orlando, FL-The first contact lens (CL) that combines the comfort of silicone hydrogel (SiH) and the convenience and eye health characteristics of a daily wear (DW) disposable lens was introduced here at the annual meeting of the American Optometric Association.

The Vistakon division of Johnson & Johnson Vision Care Inc. announced that it has received clearance from the FDA to market the first hydrogel daily disposable lens in the U.S. The company is marketing the new lens under the name 1-DAY ACUVUE TruEye.

"You really can't ask for much more in a lens," Dr. Riley said. "These lenses would be great for any patient. Patients are going to put in a fresh, clean lens every day, and the [SiH] material has a unique wetting property. The patient is going to have the health of increased oxygen and also the physiological comfort and smoothness of the wetting agent. When we combined all these areas of the technology, we really end up with the best lens possible."

Gathering data

In an ongoing 1-year, 94-subject, randomized, investigator-masked, parallel-group study, the eye health of patients wearing the DW SiH lenses was compared with that of people who have never worn CLs. After 1 month of wear, the DW SiH lenses were shown to have no significant effect on the ocular surface of the eye as compared with non-CL wearers across these CL-associated measures associated with eye health:

One measure that was found to be different between wearers of the DW SiH lenses and non-CL wearers was conjunctival staining. "[CL] products with a thin edge profile have some degree of conjunctival staining, and that's generally perceived as insignificant. But we reported that along with all the other findings," Dr. Riley said.

"This new lens is the next level up," she noted. "You're not accepting compromise. I've been a practitioner for 18 years, and I've never seen this kind of physiological response or lack of physiological response that we have with this lens. That's an exciting opportunity to think about when fitting contact lenses."

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.